Publications

Havens P.L., Stephensen C.B., Van Loan M.D., Schuster G.U., Woodhouse L.R., Flynn P.M., Gordon C.M., Pan C.G., Rutledge B., Harris D.R., Price G., Baker A., Meyer W.A., Wilson C.M., Hazra R., Kapogiannis B.G., Mulligan K., and Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 109 Study Team (2018).

Vitamin D3 supplementation increases spine bone mineral density in adolescents and young adults with human immunodeficiency virus infection being treated with tenofovir disoproxil fumarate: A randomized, placebo-controlled trial.

Havens P.L., Tamhane A., Stephensen C.B., Schuster G.U., Gordon C.M., Liu N., Wilson C.M., Hosek S.G., Anderson P.L., Kapogiannis B.G., and Mulligan K. (2018).

Association of vitamin D insufficiency and protective tenofovir diphosphate concentrations with bone toxicity in adolescent boys and young men using tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis.

Chung D.C., McCague S., Yu Z.F., Thill S., DiStefano-Pappas J., Bennett J., Cross D., Marshall K., Wellman J., and High K.A. (2018).

Novel mobility test to assess functional vision in patients with inherited retinal dystrophies.

Mollica M.A., Kent E.E., Castro K.M., Ellis E.M., Ferrer R.A., Falisi A.L., Gaysynsky A., Huang G., Palan M.A., and Chou W.S. (2018).

Perspectives on palliative care in cancer clinical trials: Diverse meanings from multidisciplinary cancer care providers.

Kapogiannis B.G., Wilson C.M., Price G.N., Harris D.R., Hazra R., Mulligan K., Havens P.L., Stephensen C.B., Flynn P.M., Rutledge B., Pan C.G., Woodhouse L.R., Van Loan M.D., Baker A., Gordon C.M., Shuster G.U., and Meyer W.A. (2018).

Vitamin D3 supplementation increases spine bone mineral density in adolescents and young adults with HIV infection being treated with tenofovir disoproxil fumarate: A randomized, placebo-controlled trial.

Mast A.E., Bialkowski W., Bryant B.J., Wright D.J., Birch R.J., Kiss J.E., D'Andrea P., Cable R.G., and Spencer B.R. (2016).

A randomized, blinded, placebo-controlled trial of education and iron supplementation for mitigation of iron deficiency in regular blood donors.

Want to work with us?
You’ll be in great company.

About Us Careers

Westat Employees.
Westat Employee.
Client List
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Internal Revenue Service
National Science Foundation
Social Security Administration
U.S. Department of Agriculture
U.S. Department of Education
U.S. Department of Justice
U.S. Department of Transportation
U.S. Department of Veterans Affairs
Georgia Department of Transportation
Maryland Cancer Registry
Michigan Department of Health and Human Services
Texas Education Agency
Baltimore Metropolitan Council
Chicago Metropolitan Agency for Planning
DC Public Schools
NYC Mayor’s Office for Economic Opportunity
Organization for Economic Cooperation and Development
AAA Foundation for Traffic Safety
ClearWay Minnesota
Robert Wood Johnson Foundation
Teach for America
The Verizon Foundation
The Johns Hopkins University
University of Denver
University of Maryland Baltimore Campus
University of Michigan
SiriusXM
Toyota
U.S. Department of Health and Human Services
Substance Abuse and Mental Health Services Administration
The National Institutes of Health
Forbes 2019: The Best Employers for DiversityForbes 2019: The Best Employers for Women

Westat is an Equal Opportunity Employer and does not discriminate on the basis of race, creed, color, religion, sex, national origin, age, veteran status, disability, marital status, sexual orientation, citizenship status, genetic information, gender identity, or any other protected status under applicable law. Notices to Employees & Applicants.